CGS.AX - Cogstate Limited Stock Price & Dividend Safety Sector: Healthcare | Exchange: Australian Securities Exchange Current Price & Safety Score Price: 3.48 AUD StockBonds Safety Grade: Altman Z-Score (Bankruptcy Risk): 20.48 StockBond Score: 3.47 Company Description Melbourne Australiabased Cogstate Limited established in 1999 is a neuroscience technology company specializing in computerized cognitive assessments and digital solutions for clinical outcome evaluations Its comprehensive suite of cognitive services includes project and data management scientific consulting statistical analysis procurement of assessment scales rater training and monitoring solutions The company operates through two distinct divisions The Clinical Trials segment delivers technology and support services designed to measure the impact of diseases pharmaceuticals medical devices or other interventions on human participants in clinical studies primarily serving pharmaceutical and biotechnology clients Concurrently its Healthcare segment offers Cognigram a system facilitating regular and standardized testing to assist primary care physicians and hospitals in the early identification of cognitive decline By June 30 2022 Cogstate had participated in an estimated 1800 academic research initiatives